Microsoft Word - 20160714_press release②_Nikko_English_vfin.doc

July 14, 2016

Notice Concerning Determination of Details of Issuance of Stock Options (Stock Acquisition Rights)

ONO PHARMACEUTICAL CO., LTD. (Osaka, Japan; President, Representative Director and CEO, Gyo Sagara; "ONO") announced that the pending conditions of Stock Options (Stock

Acquisition Rights) resolved at the meeting of Board of Directors held on June 29, 2016 have been determined today as set forth below.

  1. Total number of the Stock Acquisition Rights: 26 (The number of shares issued per Stock Acquisition Right is 500)

  2. Amount to be paid for the Stock Acquisition Rights:

    1,702,500 yen per Stock Acquisition Right (3,405 yen per share)

  3. Allottees and the number of Stock Acquisition Rights:

Allottees

Number

Number of Stock Acquisition Rights

ONO's Directors

(excluding outside directors)

5

26

Contact ONO PHARMACEUTICAL CO., LTD.

Corporate Communications public_relations@ono.co.jp

ONO Pharmaceutical Co. Ltd. published this content on 14 July 2016 and is solely responsible for the information contained herein.
Distributed by Public, unedited and unaltered, on 14 July 2016 09:13:04 UTC.

Original documenthttp://www.ono.co.jp/eng/news/pdf/sm_cn160714.pdf

Public permalinkhttp://www.publicnow.com/view/4F790B7F68E1ED1AAA70754A786E3C88060C16EC